Status:
COMPLETED
Rosacea Prevalence in General Population - Pilot Study
Lead Sponsor:
Galderma R&D
Conditions:
Rosacea
Eligibility:
All Genders
18-65 years
Brief Summary
The purpose of this study is to test and refine, a subject questionnaire aimed to be used in a general population rosacea prevalence study.
Detailed Description
The study will test the subject questionnaire aimed to be used in a full general population prevalence study to screen potential subjects with rosacea. Questionnaire will be self-administrated to Der...
Eligibility Criteria
Inclusion
- Male or Female aged between 18 (or locally accepted majority) and 65 years old both included.
- Subject visiting one of the study dermatology practices for daily care/routine dermatology consultation.
- Subject have to read and sign the approved Informed Consent form prior to any participation in the study,
- Subject willing and capable of cooperating to the extend and degree required by the protocol
Exclusion
Key Trial Info
Start Date :
August 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02292836
Start Date
August 1 2012
End Date
February 1 2013
Last Update
November 17 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Jerry TAN
Windsor, Ontario, Canada, N8W 5L7
2
Mats BERG
Eskilstuna, Sweden, S-631 88